4
Changes in Ownership
Avalo Therapeutics, Inc. Filed Acc 0001578563-24-000363
Options or other derivatives
- CEO and Chairman of the Board acquired 695,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
NEIL GARRY ARTHUR · CEO and Chairman of the Board
Table II: Derivative
2 lines| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2024-08-13 | Grant or award : show line 1 in the form Stock Option (Right to Buy) | +500,400 | 500,400 | D |
| 2024-08-13 | Grant or award : show line 2 in the form Restricted Stock Units | +194,600 | 194,600 | D |
Loading xslF345X05/primary_doc.xml…